0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Sickle Cell Disease Treatment Market Report & Forecast 2022-2028
Published Date: April 2022
|
Report Code: QYRE-Auto-30X5811
Home | Market Reports | Health | Health Conditions | Genetic Disorders
Global Sickle Cell Disease Treatment Market Size Status and Forecast 2021 2027

Global and United States Sickle Cell Disease Treatment Market Report & Forecast 2022-2028

Code: QYRE-Auto-30X5811
Report
April 2022
110 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.
Market Analysis and Insights: Global and United States Sickle Cell Disease Treatment Market
This report focuses on global and United States Sickle Cell Disease Treatment market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Sickle Cell Disease Treatment market size is estimated to be worth US$ 2157.5 million in 2022 and is forecast to a readjusted size of US$ 4132.3 million by 2028 with a CAGR of 11.4% during the review period.

Fully considering the economic change by this health crisis, by Type, Sickle Cell Anemia accounting for % of the Sickle Cell Disease Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Sickle Cell Disease Treatment market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Sickle Cell Disease Treatment Scope and Market Size
Sickle Cell Disease Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Sickle Cell Disease Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Sickle Cell Anemia
Sickle Beta Thalassemia
Sickle Hemoglobin C Disease

Segment by Application

Hospitals
Clinics
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

AstraZeneca
Eli Lilly
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird bio
Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Sanofi
CRISPR Therapeutics
Vertex Pharmaceuticals, Inc.
1 Study Coverage
1.1 Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Sickle Cell Disease Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sickle Cell Disease Treatment Market Size for the Year 2017-2028
1.2.2 Global Sickle Cell Disease Treatment Market Size for the Year 2017-2028
1.3 Sickle Cell Disease Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Sickle Cell Disease Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Sickle Cell Disease Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Sickle Cell Disease Treatment Market Dynamics
1.4.1 Sickle Cell Disease Treatment Industry Trends
1.4.2 Sickle Cell Disease Treatment Market Drivers
1.4.3 Sickle Cell Disease Treatment Market Challenges
1.4.4 Sickle Cell Disease Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Sickle Cell Disease Treatment by Type
2.1 Sickle Cell Disease Treatment Market Segment by Type
2.1.1 Sickle Cell Anemia
2.1.2 Sickle Beta Thalassemia
2.1.3 Sickle Hemoglobin C Disease
2.2 Global Sickle Cell Disease Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Sickle Cell Disease Treatment Market Size by Type (2017-2028)
2.4 United States Sickle Cell Disease Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Sickle Cell Disease Treatment Market Size by Type (2017-2028)
3 Sickle Cell Disease Treatment by Application
3.1 Sickle Cell Disease Treatment Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Sickle Cell Disease Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Sickle Cell Disease Treatment Market Size by Application (2017-2028)
3.4 United States Sickle Cell Disease Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Sickle Cell Disease Treatment Market Size by Application (2017-2028)
4 Global Sickle Cell Disease Treatment Competitor Landscape by Company
4.1 Global Sickle Cell Disease Treatment Market Size by Company
4.1.1 Top Global Sickle Cell Disease Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Sickle Cell Disease Treatment Revenue by Player (2017-2022)
4.2 Global Sickle Cell Disease Treatment Concentration Ratio (CR)
4.2.1 Sickle Cell Disease Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Sickle Cell Disease Treatment in 2021
4.2.3 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sickle Cell Disease Treatment Headquarters, Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Sickle Cell Disease Treatment Headquarters and Area Served
4.3.2 Global Sickle Cell Disease Treatment Companies Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Sickle Cell Disease Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Sickle Cell Disease Treatment Market Size by Company
4.5.1 Top Sickle Cell Disease Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sickle Cell Disease Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Sickle Cell Disease Treatment Market Size by Region
5.1 Global Sickle Cell Disease Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sickle Cell Disease Treatment Market Size by Region (2017-2028)
5.2.1 Global Sickle Cell Disease Treatment Market Size by Region: 2017-2022
5.2.2 Global Sickle Cell Disease Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sickle Cell Disease Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Sickle Cell Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sickle Cell Disease Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sickle Cell Disease Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Sickle Cell Disease Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Sickle Cell Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sickle Cell Disease Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Sickle Cell Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sickle Cell Disease Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sickle Cell Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Details
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
7.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.1.5 AstraZeneca Recent Development
7.2 Eli Lilly
7.2.1 Eli Lilly Company Details
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
7.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.2.5 Eli Lilly Recent Development
7.3 Novartis
7.3.1 Novartis Company Details
7.3.2 Novartis Business Overview
7.3.3 Novartis Sickle Cell Disease Treatment Introduction
7.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.3.5 Novartis Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Details
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Sickle Cell Disease Treatment Introduction
7.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.4.5 Pfizer Recent Development
7.5 Baxter
7.5.1 Baxter Company Details
7.5.2 Baxter Business Overview
7.5.3 Baxter Sickle Cell Disease Treatment Introduction
7.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.5.5 Baxter Recent Development
7.6 Emmaus Life Sciences
7.6.1 Emmaus Life Sciences Company Details
7.6.2 Emmaus Life Sciences Business Overview
7.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
7.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.6.5 Emmaus Life Sciences Recent Development
7.7 Bluebird bio
7.7.1 Bluebird bio Company Details
7.7.2 Bluebird bio Business Overview
7.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
7.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.7.5 Bluebird bio Recent Development
7.8 Blood Therapeutics
7.8.1 Blood Therapeutics Company Details
7.8.2 Blood Therapeutics Business Overview
7.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
7.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.8.5 Blood Therapeutics Recent Development
7.9 Sangamo Therapeutics
7.9.1 Sangamo Therapeutics Company Details
7.9.2 Sangamo Therapeutics Business Overview
7.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
7.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.9.5 Sangamo Therapeutics Recent Development
7.10 Acceleron Pharma
7.10.1 Acceleron Pharma Company Details
7.10.2 Acceleron Pharma Business Overview
7.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
7.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.10.5 Acceleron Pharma Recent Development
7.11 Arena Pharmaceuticals
7.11.1 Arena Pharmaceuticals Company Details
7.11.2 Arena Pharmaceuticals Business Overview
7.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
7.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.11.5 Arena Pharmaceuticals Recent Development
7.12 Alnylam Pharmaceuticals
7.12.1 Alnylam Pharmaceuticals Company Details
7.12.2 Alnylam Pharmaceuticals Business Overview
7.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
7.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.12.5 Alnylam Pharmaceuticals Recent Development
7.13 Sanofi
7.13.1 Sanofi Company Details
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Sickle Cell Disease Treatment Introduction
7.13.4 Sanofi Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.13.5 Sanofi Recent Development
7.14 CRISPR Therapeutics
7.14.1 CRISPR Therapeutics Company Details
7.14.2 CRISPR Therapeutics Business Overview
7.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Introduction
7.14.4 CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.14.5 CRISPR Therapeutics Recent Development
7.15 Vertex Pharmaceuticals, Inc.
7.15.1 Vertex Pharmaceuticals, Inc. Company Details
7.15.2 Vertex Pharmaceuticals, Inc. Business Overview
7.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Introduction
7.15.4 Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2017-2022)
7.15.5 Vertex Pharmaceuticals, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
    Table 1. Sickle Cell Disease Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Sickle Cell Disease Treatment Market Trends
    Table 3. Sickle Cell Disease Treatment Market Drivers
    Table 4. Sickle Cell Disease Treatment Market Challenges
    Table 5. Sickle Cell Disease Treatment Market Restraints
    Table 6. Global Sickle Cell Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sickle Cell Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sickle Cell Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sickle Cell Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sickle Cell Disease Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sickle Cell Disease Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Sickle Cell Disease Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Sickle Cell Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Sickle Cell Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2021)
    Table 15. Top Players of Sickle Cell Disease Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Sickle Cell Disease Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Sickle Cell Disease Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Sickle Cell Disease Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Sickle Cell Disease Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Sickle Cell Disease Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Sickle Cell Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Sickle Cell Disease Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Sickle Cell Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Sickle Cell Disease Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Sickle Cell Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Sickle Cell Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Sickle Cell Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AstraZeneca Company Details
    Table 31. AstraZeneca Business Overview
    Table 32. AstraZeneca Sickle Cell Disease Treatment Product
    Table 33. AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 34. AstraZeneca Recent Development
    Table 35. Eli Lilly Company Details
    Table 36. Eli Lilly Business Overview
    Table 37. Eli Lilly Sickle Cell Disease Treatment Product
    Table 38. Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 39. Eli Lilly Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Sickle Cell Disease Treatment Product
    Table 43. Novartis Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Pfizer Company Details
    Table 46. Pfizer Business Overview
    Table 47. Pfizer Sickle Cell Disease Treatment Product
    Table 48. Pfizer Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 49. Pfizer Recent Development
    Table 50. Baxter Company Details
    Table 51. Baxter Business Overview
    Table 52. Baxter Sickle Cell Disease Treatment Product
    Table 53. Baxter Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 54. Baxter Recent Development
    Table 55. Emmaus Life Sciences Company Details
    Table 56. Emmaus Life Sciences Business Overview
    Table 57. Emmaus Life Sciences Sickle Cell Disease Treatment Product
    Table 58. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 59. Emmaus Life Sciences Recent Development
    Table 60. Bluebird bio Company Details
    Table 61. Bluebird bio Business Overview
    Table 62. Bluebird bio Sickle Cell Disease Treatment Product
    Table 63. Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 64. Bluebird bio Recent Development
    Table 65. Blood Therapeutics Company Details
    Table 66. Blood Therapeutics Business Overview
    Table 67. Blood Therapeutics Sickle Cell Disease Treatment Product
    Table 68. Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 69. Blood Therapeutics Recent Development
    Table 70. Sangamo Therapeutics Company Details
    Table 71. Sangamo Therapeutics Business Overview
    Table 72. Sangamo Therapeutics Sickle Cell Disease Treatment Product
    Table 73. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 74. Sangamo Therapeutics Recent Development
    Table 75. Acceleron Pharma Company Details
    Table 76. Acceleron Pharma Business Overview
    Table 77. Acceleron Pharma Sickle Cell Disease Treatment Product
    Table 78. Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 79. Acceleron Pharma Recent Development
    Table 80. Arena Pharmaceuticals Company Details
    Table 81. Arena Pharmaceuticals Business Overview
    Table 82. Arena Pharmaceuticals Sickle Cell Disease Treatment Product
    Table 83. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 84. Arena Pharmaceuticals Recent Development
    Table 85. Alnylam Pharmaceuticals Company Details
    Table 86. Alnylam Pharmaceuticals Business Overview
    Table 87. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product
    Table 88. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 89. Alnylam Pharmaceuticals Recent Development
    Table 90. Sanofi Company Details
    Table 91. Sanofi Business Overview
    Table 92. Sanofi Sickle Cell Disease Treatment Product
    Table 93. Sanofi Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 94. Sanofi Recent Development
    Table 95. CRISPR Therapeutics Company Details
    Table 96. CRISPR Therapeutics Business Overview
    Table 97. CRISPR Therapeutics Sickle Cell Disease Treatment Product
    Table 98. CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 99. CRISPR Therapeutics Recent Development
    Table 100. Vertex Pharmaceuticals, Inc. Company Details
    Table 101. Vertex Pharmaceuticals, Inc. Business Overview
    Table 102. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Product
    Table 103. Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2017-2022) & (US$ Million)
    Table 104. Vertex Pharmaceuticals, Inc. Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sickle Cell Disease Treatment Product Picture
    Figure 2. Global Sickle Cell Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sickle Cell Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Sickle Cell Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Sickle Cell Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Sickle Cell Disease Treatment Market Share in Global 2017-2028
    Figure 7. Sickle Cell Disease Treatment Report Years Considered
    Figure 8. Product Picture of Sickle Cell Anemia
    Figure 9. Product Picture of Sickle Beta Thalassemia
    Figure 10. Product Picture of Sickle Hemoglobin C Disease
    Figure 11. Global Sickle Cell Disease Treatment Market Share by Type in 2022 & 2028
    Figure 12. Global Sickle Cell Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Sickle Cell Disease Treatment Market Share by Type (2017-2028)
    Figure 14. United States Sickle Cell Disease Treatment Market Share by Type in 2022 & 2028
    Figure 15. United States Sickle Cell Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Sickle Cell Disease Treatment Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Others
    Figure 20. Global Sickle Cell Disease Treatment Market Share by Application in 2022 & 2028
    Figure 21. Global Sickle Cell Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Sickle Cell Disease Treatment Market Share by Application (2017-2028)
    Figure 23. United States Sickle Cell Disease Treatment Market Share by Application in 2022 & 2028
    Figure 24. United States Sickle Cell Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Sickle Cell Disease Treatment Market Share by Application (2017-2028)
    Figure 26. North America Sickle Cell Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. United States Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Sickle Cell Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Sickle Cell Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. China Taiwan Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Sickle Cell Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Sickle Cell Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Sickle Cell Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 54. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 57. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 58. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 59. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 60. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 61. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 62. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 64. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 65. Sanofi Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 66. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 67. Vertex Pharmaceuticals, Inc. Revenue Growth Rate in Sickle Cell Disease Treatment Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sickle Cell Disease Treatment Market Size Status and Forecast 2021 2027
Global and United States Sickle Cell Disease Treatment Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30X5811
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

Global Fanconi Anemia Treatment Market Research Report 2022
Global Fanconi Anemia Treatment Market Research Report 2022

Fanconi anemia is indicated by shortness of breath frequent nasal bleeding weariness recurring viral infection and cold low stature and poor growth are all indications of fanconi anemia.The global Fanconi Anemia Treatment market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Blood and Bone Marrow Transplant accounting for of the Fanconi Anemia Treatment global market in 2021 is projected to value US million by 2028 growing at a revised CAGR from 2022 to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-32A10288
Wed Mar 30 00:00:00 UTC 2022

Add to Cart

Global Adrenoleukodystrophy Treatment Market Research Report 2022
Global Adrenoleukodystrophy Treatment Market Research Report 2022

Childhood cerebral ALD is known to progress rapidly in children between the ages of 3 and 10.The global Adrenoleukodystrophy Treatment market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Oral Drugs accounting for of the Adrenoleukodystrophy Treatment global market in 2021 is projected to value US million by 2028 growing at a revised CAGR from 2022 to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-14J10425
Wed Mar 23 00:00:00 UTC 2022

Add to Cart

Global Krabbe Disease Treatment Market Insights Forecast to 2028
Global Krabbe Disease Treatment Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-28R1610
Mon Mar 14 00:00:00 UTC 2022

Add to Cart